XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity (Details) - USD ($)
 1 Months Ended 2 Months Ended 9 Months Ended 12 Months Ended
May 06, 2016
Mar. 21, 2016
Feb. 08, 2016
Feb. 28, 2017
Oct. 31, 2016
Aug. 26, 2016
Feb. 17, 2016
Sep. 30, 2015
Jun. 30, 2017
Jun. 30, 2016
Sep. 30, 2016
Dec. 29, 2015
Oct. 30, 2015
Equity (Textual)                          
Common stock, authorized   360,000,000           360,000,000 360,000,000   360,000,000    
Common stock, par value   $ 0.001           $ 0.001 $ 0.001   $ 0.001    
Description of forward split   1 to 3.141                      
Subscription receivable               $ 350,000       $ 350,000
Issuance of common shares               51,958     3,250,000    
Payment of American BriVision               22,517 $ 953,000   6,500,000    
Consulting agreement, description        
The Company entered into a Consulting Agreement with Kazunori Kameyama ("Kameyama") for the provision of services related to the clinical trials and other administrative work, public relation work, capital raising, trip coordination, In consideration for providing such services, the Company agreed to indemnify the consultant in an amount of $150 per hour in cash up to $3,000 per month, and issue to Kameyama the Company’s common stock at $1.00 per share for any amount exceeding $3,000. The Company’s stocks will be calculated and issued in December every year. The contract will be terminated on September 30, 2017. For the nine months ended on June 30, 2017, the Company recognized (as appropriate relative to the periods and manner that the Company would recognize cash payments under the same arrangement) the cost of the appropriate number of the 1,688 shares at the current fair value as of December 31, 2016 and June 30, 2017.
                
Stock based compensation               5,928 $ 897,521 1,295,324    
2016 Plan [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split             50,000            
Common stock issued post-stock split             157,050            
Biolite Inc [Member]                          
Equity (Textual)                          
Payment of American BriVision                   $ 6,500,000    
Share Exchange Agreement [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split     52,336,000                    
Common stock issued post-stock split     164,387,376                    
Share Exchange Agreement 1 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split     52,936,583                    
Common stock issued post-stock split     166,273,921                    
Share Exchange Agreement 2 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split     51,945,225                    
Common stock issued post-stock split     163,159,952                    
Percentage of common shares issued and outstanding     79.70%                    
Percentage of issued share capital     100.00%                    
Share Exchange Agreement 3 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split     52,936,583                    
Common stock issued post-stock split     166,273,921                    
Exchange ratio     0.2536-for-1                    
Share Exchange Agreement 4 [Member]                          
Equity (Textual)                          
Common stock issued pre-stock split     65,431,144                    
Common stock issued post-stock split     205,519,223                    
Percentage of common shares issued and outstanding     79.70%                    
Collaborative Arrangement [Member]                          
Equity (Textual)                          
Issuance of common shares $ 900,000                        
Issuance of common shares, shares 562,500                        
Share price $ 1.60                        
Payment of American BriVision                       $ 100,000,000  
Percentage of payments under collaborative agreement                     3.50%    
Collaborative Arrangement One [Member]                          
Equity (Textual)                          
Issuance of common shares       $ 5,850,000                  
Issuance of common shares, shares       2,925,000                  
Share price       $ 2.0                  
Percentage of payments under collaborative agreement                   6.50% 6.50%    
Total payment upon first IND submission                   $ 6,500,000 $ 6,500,000    
Remitted amount       $ 650,000                  
Stock Purchase Agreement [Member] | Biolite Inc [Member]                          
Equity (Textual)                          
Common stock, par value           $ 0.001              
Issuance of common shares, shares           1,468,750              
Purchase price per share           $ 1.60              
Net proceeds from offering           $ 2,350,000